Pfizer said on Tuesday the next few years will be bumpy, beginning with 2026, due to lower sales of its COVID vaccine and ...
Pfizer's profits will fall short of Wall Street estimates next year, as it faces weaker sales of COVID products and squeezed ...
Pfizer's COVID-19 vaccine has become the first in the U.S. to receive full approval from the FDA for people ages 16 and up.
The U.S. Food and Drug Administration is considering adding the strongest safety warning available to COVID-19 vaccines, ...
People familiar with the plan told CNN the FDA is weighing whether to place a black box warning on COVID vaccines. These ...
On December 14, 2020 I became the first person in the United States to receive the first FDA-approved COVID-19 vaccine. Now, ...
The Food and Drug Administration (FDA) is investigating whether the COVID-19 vaccines were associated with any deaths across ...
The FDA is reportedly considering the addition of high-level warning labels to COVID vaccines, a move that some experts say ...
The U.S. Food and Drug Administration intends to put a "black box" warning on COVID-19 vaccines, CNN reported on Friday, ...
Pfizer (PFE) stock falls, and its COVID vaccine peers such as Moderna (MRNA) and Novavax (NVAX) also drop as the company ...
Alongside its cost-cutting strategy, Pfizer has been investing into its cardiometabolic pipeline in a bid to enter the ...
Pfizer CEO Albert Bourla defended his company’s vaccine business as rhetoric from HHS Secretary Robert F. Kennedy Jr. drives ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback